> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fraudulent Contract Research Org. Leads to Debarment
- URL: https://www.fdaweb.com/fraudulent-contract-research-org-leads-to-debarment/
- Published: 2023-02-02T12:00:00.000Z
- Updated: 2026-09-14T18:14:23.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5153683

*Federal Register* notice: FDA has issued an order permanently debarring **Sami Anwar** from providing services related to an approved or pending drug product application. The debarment is related to his recent convictions as the owner and operator of Mid-Columbia Research LLC and Zain Research LLC, contract research organizations that oversaw and conducted clinical research trials for various drug sponsors. Court documents allege Anwar’s companies fraudulently posed as legitimate human clinical research trial sites and provided false clinical research trial data regarding drug safety and drug efficacy to dozens of drug companies. Anwar also posed as a doctor and forged the signatures of the doctors he employed. In addition, Anwar had his employees assist in committing the fraud by: (**1**) producing false medical records and data to admit dozens of ineligible research subjects, (**2**) falsifying research data vital signs, (**3**) stealing blood samples taken from patients without their consent, (**4**) directing patients to dispose of study meds and then falsely record dispensing as required by the study, (**5**) fraudulently obtaining opioids intended to be dispensed to study subjects, and (**6**) falsifying subject diaries. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-02-02/pdf/2023-02161.pdf?ref=fdaweb.com).